title: [Is it Possible to Improve Results in the Conservative Treatment Strategy in Patients With Acute Coronary Syndrome?]
abstract: Almost 60% of patients with acute coronary syndrome (ACS) without ST segment elevation are not subjected to revascularization procedures. This review analyzes the reasons for the choice of the conservative tactics of patients with ACS. The possibilities of improving outcomes by using modern medicines. Particular attention is given to drugs that affect energy metabolism in cardiomyocytes ischemia and reperfusion, provides data on the effect of L-carnitine on the high-risk markers, and decrease the incidence of adverse outcomes in patients with ACS.
authors.affiliation: Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: M G
authors.initials: MG
authors.lastname: Gleser
authors.affiliation: Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: E I
authors.initials: EI
authors.lastname: Astashkin
authors.affiliation: Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: A E
authors.initials: AE
authors.lastname: Kiseleva
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy*; D000072700:Conservative Treatment; D006801:Humans; D018570:Risk Assessment; D016896:Treatment Outcome
keywords: L-carnitine; acute coronary syndrome; anticoagulants; antiplatelets; conservative treatment; metabolic cytoprotectors; trimetazidine